$157.47
2.31%
NYSE, Apr 17, 10:16 pm CET
ISIN
US4781601046
Symbol
JNJ

Johnson & Johnson Stock price

$157.47
-5.37 3.30% 1M
-7.00 4.26% 6M
+12.85 8.89% YTD
+12.70 8.77% 1Y
-20.19 11.36% 3Y
+5.45 3.59% 5Y
+57.89 58.13% 10Y
NYSE, Closing price Thu, Apr 17 2025
+3.56 2.31%
ISIN
US4781601046
Symbol
JNJ
Sector
Industry

Key metrics

Market capitalization $379.48b
P/E (TTM) P/E ratio 17.50
P/S ratio (TTM) P/S ratio 4.25
P/B ratio (TTM) P/B ratio 5.30
Dividend yield 3.12%
Last dividend (FY24) $4.91
Revenue growth (TTM) Revenue growth -0.37%
Revenue (TTM) Revenue $89.33b
EBIT (operating result TTM) EBIT $21.19b
Cash position $24.52b
EPS (TTM) EPS $9.00
P/E forward 15.45
P/S forward 4.17
Short interest 0.79%
Show more

Create a Free Account to create an Johnson & Johnson alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Johnson & Johnson Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Johnson & Johnson forecast:

11x Buy
46%
13x Hold
54%

Analyst Opinions

24 Analysts have issued a Johnson & Johnson forecast:

Buy
46%
Hold
54%

Financial data from Johnson & Johnson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
89,330 89,330
0% 0%
100%
- Direct Costs 27,353 27,353
3% 3%
31%
67,501 67,501
10% 10%
76%
- Selling and Administrative Expenses 23,844 23,844
52% 52%
27%
- Research and Development Expense 16,944 16,944
11% 11%
19%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 21,189 21,189
8% 8%
24%
Net Profit 21,810 21,810
25% 25%
24%

In millions USD.

Don't miss a Thing! We will send you all news about Johnson & Johnson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Johnson & Johnson Stock News

Positive
The Motley Fool
about 10 hours ago
Dividend stocks can be fantastic investments. The best ones pay an attractive and growing stream of dividend income while also delivering healthy stock price appreciation over the long term.
Positive
PYMNTS
one day ago
Johnson & Johnson reportedly found that 10% to 15% of artificial intelligence use cases deliver 80% of the value.
Positive
24/7 Wall Street
one day ago
Investors love dividend stocks, especially the high-yield variety, because they offer a significant income stream and have massive total return potential.
More Johnson & Johnson News

Company Profile

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Head office United States
CEO Joaquin Duato
Employees 138,100
Founded 1887
Website www.jnj.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today